Welcome, sign in or click here to subscribe.
Login: Password:




Email to a friend   Print   Comment   Reprints   Add to myDJC   Adjust font size

November 30, 2017

Juno Therapeutics

Juno Therapeutics, a Seattle biopharmaceutical company developing immunotherapies for treating cancer, named Ann L. Lee, Ph.D., executive vice president of technical operations. Dr. Patrick Y. Yang will assume the role of executive vice president and senior advisor to the CEO. Both will report to Hans Bishop, president and CEO. Lee held senior positions at RocheGenentech and Merck & Co.